Volker Knappertz

Chief Medical Officer, GW PHARMACEUTICALS PLC.

Companies

Aurinia Pharmaceuticals Inc.EVP, Research and Development Jul 19, 2022 to Feb 29, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Aurinia Pharmaceuticals Inc. AUPH319,128 shares²$5.3M at $16.51Feb 27, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 27, 2024Sold 4,930 shares at $6.10 of Aurinia Pharmaceuticals Inc.²
Feb 20, 2024Sold 25,146 shares at $5.48 of Aurinia Pharmaceuticals Inc.³
Mar 2, 2023Granted 191,462 shares of Aurinia Pharmaceuticals Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAurinia Pharmaceuticals Inc., EVP, Research and Development
2
SEC EDGARAurinia Pharmaceuticals Inc. shares after the filing of Feb 27, 2024
3
SEC EDGARForm 4 filed Feb 22, 2024
4
SEC EDGARForm 4 filed Mar 6, 2023